InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Jacob Gary S, Chairman & CEO. Director active across 1 company, notably OKYO Pharma Ltd. In total, 3 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €52k. Activity tracked since 19 May 2022. The latest transaction was filed on 21 July 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Gary S. Jacob is the Chief Executive Officer of OKYO Pharma Ltd. He leads the company with a vision focused on innovation in the pharmaceutical field, aiming to develop innovative treatments for patients.